Find a Provider

Mark A. Morgan, MD

Mark A. Morgan, MD Physician

Chief, Gynecology Oncology
Director, Gynecology Oncology at Pennsylvania Hospital
John J. Mikuta, M.D. Professor of Gynecologic Oncology

Dr. Morgan is a Penn Medicine employed physician.

About Dr. Mark A. Morgan

Recognized annually in Philadelphia Magazine's Top Doc Issue from 1994 through 2015

Recognized by America's Top Doctors 2008-2014

Recognized by Best Doctors in America 2007-2012, 2013-2014

Clinical Specialties


  • Obstetrics & Gynecology

Programs & Services:

  • Cancer
    • Cervical Cancer
    • Endometrial Cancer
    • Fallopian Tube Cancer
    • Gynecologic Oncology
    • Jordan Center for Gynecologic Cancers
    • Merkel Cell Carcinoma
    • Ovarian Cancer
    • Uterine Cancer
    • Vaginal Cancer
    • Vulvar Cancer

Board Certification:

  • Obstetrics and Gynecology - Gynecologic Oncology, 1992
  • Obstetrics and Gynecology, 1989

Conditions & Treatments:

  • Cervical Cancer
  • Cervical Dysplasia
  • cervical lesions
  • cervix biopsy
  • colposcopy
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Gynecologic Cancer
  • gynecologic cancer surgery
  • Gynecologic Surgery
  • gynecological chemotherapy
  • gynecology clinical trials
  • hysterectomy
  • hysterectomy - laparoscopic
  • hysterectomy - minimally invasive
  • Hysteroscopy
  • laparoscopic hysterectomy
  • Laparoscopic Surgery
  • Laparoscopy
  • LEEP procedure
  • Ovarian Cancer
  • Robotic Surgery
  • supracervical hysterectomy - laparoscopic
  • Trophoblastic Cancer
  • Uterine Cancer
  • Vaginal Cancer
  • Vulvar Cancer

Clinical Interests

Gynecologic Oncology; Urogynecology

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Multiplan
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Rail Road Medicare / Palmetto GBA
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: State University of New York at Brooklyn
Residency: Hospital of the University of Pennsylvania
Fellowship: Hospital of the University of Pennsylvania


American College of Obstetricians and Gynecologists, National American College of Surgeons, National American Society for Colposcopy and Cervical Pathology, National American Society of Clinical Oncology, National American Urogynecologic Society, National College of Physicians of Philadelphia, Local Gynecologic Oncology Group, National International Gynecologic Cancer Society, International National Comprehensive Cancer Network, National Philadelphia Obstetrical Society, Local Society of Gynecologic Oncologists, National Society of Pelvic Surgeons, National World Health Organization, International


Dr. Morgan is a Penn Medicine employed physician.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Research Interests:

Clinical trials

Selected Publications:

Farley J, Brady WE, Vathipadiekal V, Lankes HA, Coleman R, Morgan MA, Mannel R, Yamada SD, Mutch D, Rodgers WH, Birrer M, Gershenson DM: Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or perineum: an open label, single-arm, phase 2 study. The Lancet 4(2):134-140 : 2013.

Myers SB, Manne SL, Kissane DW, Ozga M, Kashy DA, Rubin S, Heckman C, Rosenblum N, Morgan M, Graff JJ: Social-cognitive processes associated with fear of recurrence among women newly diagnosed with gynecologic cancers. Gynecol Oncol 128(1):120-127 : 2013.

Chu CS, Boyer J, Schullery DS, Gimotty PA, Gamerman V, Bender J, Levine BL, Coukos G, Rubin SC, Morgan MA, Vonderheide RH, June CH: Phase I/II randomized trial of dendritic cell vaccination with or without cyclophosphamide for consolidation therapy of advanced ovarian cancer in first or second remission. Cancer Immunol Immunother 61(5):629-641. : 2012.

Morgan MA, Sill MW, Fujiwara K, Greer B, Rubin SC, DeGeest K, Yamada SD, Waggoner S, Coleman, RL, Walker JL, Mannel RS: A Phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in unreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol 121(2):264-68 : 2011.

Greer BE, Koh WJ, Abu-Rustum NR, Apte SM, Campos SM, Chan J, Cho KR, Copeland L, Crispens MA, DuPont N, Eifel PJ, Gaffney DK, Huh WK, Kapp DS, Lurain JR, Martin L, Morgan MA, Morgan RJ, Mutch D, Remmenga SW, Reynolds RK, Small W, Teng N, Valea FA: Cervical Cancer. J Nat’l Compr Canc Netw 8(12):1388-416 : 2010.

Greer BE, Koh WJ, Abu-Rustum N, Bookman, MA, Bristow RE, Campos SM, Cho, KR, Copeland L, Crispens MA, Eifel PJ, Huh WK, Jagernauth W, Kapp DS, Kavanagh JJ, Lurain JR 3rd, Morgan MA, Morgan RJ, Powell CB, Remmenga SW, Reynolds RK, Alvarez Secord A, Small W Jr., Teng N.: NCCN Clinical Practice Guidelines in Oncology: Uterine Neoplasms. J Natl Compr Canc Netw 7(5):498-531 : 2009.

Kavanagh JJ, Sill MW, Ramirez PT, Warshal D, Pearl ML, Morgan MA: Phase II multicenter open-label study of karenitecin in previously treated epithelial ovarian and primary peritoneal cancer: A Gynecologic Oncology Group Study. Int J Gynecol Cancer 18(3):460-464 : 2008.

Morgan MA, Polan ML, Melecot HH, Debru B, Sleemi A, Husain A: Experience with a low-pressure colonic pouch (Mainz II) urinary diversion for irreparable vesicovaginal fistula and bladder extrophy in East Africa. Int Urogynecol J 20:1163-1168 : 2009.

Morgan, MA: Intraperitoneal chemotherapy for ovarian cancer. Adv Exp Med Biol 622:145-51 : 2008.

Morgan MA, Darcy KM, Rose PG, DeGeest K, Bookman MA, Aikins JK, Sill MW, Mannel RS, Allievi C, Egorin MJ: Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group. Gynecologic Oncology 110:329-335 : 2008.

Academic Contact Info

Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
3rd Floor West

Philadelphia, PA 19104
Phone: (215) 662-3318
Fax: (215) 349-5849
Patient appointments: 800-789-PENN (7366)